HCPLive

Rheumatoid Arthritis 
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Balancing Treatment and Disease Burden of Arthritis in Young Patients
Researchers explored how people aged 16 to 25 years old with inflammatory arthritis evaluate the risks and benefits of treatment. They especially wanted to focus on the patients’ assessments of biologic therapies.
It’s been reiterated time and time again but the evidence holds true – smoking leads to worse health outcomes. However, smoking increases the risk of death in patients with rheumatoid arthritis.
Researchers from Stanford University Medical Center studied patients with inadequate or unacceptable side effects associated with one or more tumor necrosis factor inhibitors or other biologic DMARDs, or both.
John D. Reveille, MD, provides insight on a variety of diagnostic tools used for assessing disease activity in ankylosing spondylitis.
John D. Reveille, MD, discusses the characteristics of ankylosing spondylitis, including how patients present and the distinguishing features versus rheumatoid arthritis.
The symptoms and pathology of rheumatoid arthritis (RA) worsened in mice models, which were missing the enzyme needed for serotonin synthesis, according to findings published in The American Journal of Pathology.
Autoimmune diseases like rheumatoid arthritis (RA) and Crohn’s disease are “gonna be defeated”, according to findings published in the Proceedings of the National Academy of Sciences.
Researchers treated mice with transforming growth factor β–activated kinase 1 (TAK 1) in order to examine the post-translational modification to TAK 1 and its therapeutic regulation in rheumatoid arthritis. The team used a phytochemical known as epigallocatechin 3 gallate (a compound commonly found in green tea) in a 10-day treatment plan in the mice to study the effects.
Patients with arthritis may eventually be able to use their own "microvesicles" as treatment for their disease.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$